Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1561-2022Class I

NeuRx Diaphragm Pacing System (NeuRx DPS) External Pulse Generator (EPG), Part No. 23-0021

Synapse Biomedical Inc / initiated 2022-07-11 / Terminated / root cause: manufacturing process

Synapse Biomedical Inc began a recall of NeuRx Diaphragm Pacing System (NeuRx DPS) External Pulse Generator (EPG), Part No. 23-0021 on . FDA classified it as Class I and gives the reason as "Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1561-2022
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Synapse Biomedical Inc
Product
NeuRx Diaphragm Pacing System (NeuRx DPS) External Pulse Generator (EPG), Part No. 23-0021.
Product code
OIR Diaphragmatic/Phrenic Nerve Laparoscopically-Implanted Stimulator
Reason for recall
Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and decreased breathing effectiveness, arrhythmia or cardiac arrest, or the device may stop unexpectedly.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On July 11, 2022, Synapse began contacting affected clinical sites where the devices were sent. An initial phone call was made to clinicians that have affected devices at their site or have patients with affected devices. A follow-up email is being sent each of the clinicians that includes a fact sheet for them about the recall, a fact sheet for patients that clinicians can forward to the patients and information about the specific EPGs that have been sent to their site. Patients are asked to register their devices at a webpage specifically developed for the purpose. Replacement devices are available from the manufacturer and arrangements are being made with clinicians and patients to have the devices programmed and delivered to patients as soon as possible. The manufacturer is asking that all devices be returned to Synapse Biomedical for disposal to ensure that no affected devices are inadvertently used at a later time.
Quantity in commerce
118 (112 US, 6 OUS)
Distribution
distribution to US states of AL, CO, IL, FL, GA, MD, MN, NC, NJ, OH, PA, and SC; Germany and Kuwait. ***Updated 3/28/23 - Product was not distributed to United Arab Emirates. Product was distributed to Kuwait.*** Updated 9.14.23 - 1 patient in Germany, 1 patient in the Czech Republic, 1 distributor in Kuwait
Product codes and lots
UDI-DI: 00852184003212; Serial Nos. 1900 thru 2017

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1561-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1561-2022Class ITerminatedVoluntary: Firm initiated